| abstract |
Provided herein is a pharmaceutically acceptable salt of 3,5-diaminopyrazole, such as a compound of formula (IA), useful for modulating regulated in COPD kinase activity. Pharmaceutically acceptable salts and pharmaceutical compositions thereof. Also provided herein are methods for their use to treat, prevent, or ameliorate one or more symptoms of an RC kinase-mediated disorder, disease, or condition. [Chemical 1] [Selection figure] None |